DrugsControl Media Services
DrugsControl.org

News Detail

Inappropriate use of 'Sulopenem' could cause antimicrobial resistance (AMR) (07-09-2024)

Maryland, 7 Sept 2024: Five months after signing off on Utility Therapeutics’ Pivya as the first new treatment for uncomplicated urin......
View Details

Source : Fierce Pharma
Iterum Therapeutics FDA Biotech Sulopenem antimicrobial resistance (AMR)

Related News